NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
10/17/2023
Back to search
Official data from USPTO
IMMUNOLIGHT
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
34
Latest update
10/17/2023
Trademark type
Word
Nice classes
5
Filing date
08/26/2022
Registration date
10/17/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/17/2023
Last transaction
10/17/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
05/31/2022
First use in commerce
05/31/2022
Drawing code
4
Owner type
16
Owner location
Detroit, MI
Examiner
DUENAS, TAYLOR S
Law office
N80
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
IMMUNOLIGHT, LLC
Representatives
Heather M. Barnes Tucker Ellis LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment of cancer
Publications
History of USPTO decisions and trademark events.
34 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
10/17/2023
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
09/13/2023
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
09/12/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
08/25/2023
SUPC
STATEMENT OF USE PROCESSING COMPLETE
08/24/2023
DPCC
DIVISIONAL PROCESSING COMPLETE
08/24/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
08/24/2023
IUAF
USE AMENDMENT FILED
08/03/2023
EX1G
SOU EXTENSION 1 GRANTED
08/03/2023
EXT1
SOU EXTENSION 1 FILED
08/03/2023
DRRR
DIVISIONAL REQUEST RECEIVED
08/03/2023
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
08/03/2023
EEXT
SOU TEAS EXTENSION RECEIVED
08/03/2023
EISU
TEAS STATEMENT OF USE RECEIVED
08/03/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
04/11/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/14/2023
PUBO
PUBLISHED FOR OPPOSITION
02/14/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/25/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/11/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/10/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/10/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/10/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/27/2022
GNRT
NON-FINAL ACTION E-MAILED
12/27/2022
CNRT
NON-FINAL ACTION WRITTEN
12/27/2022
DOCK
ASSIGNED TO EXAMINER
12/27/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
11/02/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/02/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/02/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/02/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
11/02/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/14/2022
NWAP
NEW APPLICATION ENTERED
08/30/2022
Continuous trademark protection
Get notified about every new filing that threatens IMMUNOLIGHT or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.